Lipid biomarkers of GVHD in allogeneic stem hematopoietic cell transplantation patients
Early post-transplant HDL-C dynamics represent a promising biomarker for GVHD risk stratification. These findings support the incorporation of protocolized lipid monitoring into HSCT management to guide preemptive therapeutic interventions.
Authors
- Yan Lü (ORCID: https://orcid.org/0000-0001-5353-4362)
- Jiao Liu
- Xin Li (ORCID: https://orcid.org/0000-0002-9466-2659)
- Jie Shen (ORCID: https://orcid.org/0009-0003-6802-4252)
- Dan Wang (ORCID: https://orcid.org/0000-0002-3946-6305)
- Yicheng Fu
- Lin Zhi (ORCID: https://orcid.org/0009-0004-5829-3771)
Institutions
- Central South University (CN)
- Third Affiliated Hospital of Guangzhou Medical University (CN)
- Hunan Cancer Hospital (CN)
- Third Xiangya Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-09-02
- DOI
- https://doi.org/10.3389/fimmu.2025.1624168
- Citations
- 1
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- Chongqing Municipal Health Commission
- National Natural Science Foundation of China
- Central South University
- Xiangya Hospital, Central South University